Banque Cantonale Vaudoise’s VanEck Pharmaceutical ETF PPH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155	Sell	1,416 -491	-26%	-$50.8K	﹤0.01%	666
2026 Q1	$198K	Buy	1,907 +115	+6%	+$12.3K	0.01%	637
2025 Q4	$185K	Buy	1,792 +1,180	+193%	+$115K	0.01%	578
2025 Q3	$55K	Sell	612 -17	-3%	-$1.49K	﹤0.01%	679
2025 Q2	$55K	Hold	629	–	–	﹤0.01%	640
2025 Q1	$57K	Buy	+629	New	+$56.6K	﹤0.01%	672
2024 Q3	$64K	Hold	672	–	–	﹤0.01%	602
2024 Q2	$61K	Hold	672	–	–	﹤0.01%	759
2024 Q1	$61K	Buy	672 +3	+0.4%	+$263	﹤0.01%	751
2023 Q4	$54K	Sell	669 -41	-6%	-$3.21K	﹤0.01%	784
2023 Q3	$57K	Hold	710	–	–	﹤0.01%	951
2023 Q2	$56K	Sell	710 -45	-6%	-$3.52K	﹤0.01%	953
2023 Q1	$59K	Buy	755 +30	+4%	+$2.31K	﹤0.01%	928
2022 Q4	$56K	Buy	+725	New	+$53.5K	﹤0.01%	940

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Banque Cantonale Vaudoise's PPH Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its VanEck Pharmaceutical ETF (PPH) stake by 26% in Q2 2026, selling an estimated $50.8K and leaving 1,416 shares worth $155. The position accounts for ﹤0.01% of the portfolio, ranked #666.

Banque Cantonale Vaudoise first reported a position in PPH in Q4 2022 and has held it in 14 quarters since. The position peaked at $198K in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Banque Cantonale Vaudoise held 1,416 shares of VanEck Pharmaceutical ETF worth $155 as of Q2 2026.
Banque Cantonale Vaudoise sold 491 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $50.8K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #666 holding.
Banque Cantonale Vaudoise first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 14 quarters since.
Banque Cantonale Vaudoise's VanEck Pharmaceutical ETF position peaked at $198K in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.